Back
Agios Pharmaceuticals, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
6
AGIO
Agios Pharmaceuticals, Inc.
Last Price:
$27.43
Seasonality Move:
8.29%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAgios Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Agios Pharmaceuticals, Inc. has on average historically risen by 38% based on the past 12 years of stock performance.
-
Agios Pharmaceuticals, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Agios Pharmaceuticals, Inc. Stock Undervalued?The current Agios Pharmaceuticals, Inc. [AGIO] share price is $27.42. The Score for AGIO is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Agios Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Agios Pharmaceuticals, Inc. has on average historically risen by 38% based on the past 12 years of stock performance.
Agios Pharmaceuticals, Inc. Stock Rating
Sell
6
Agios Pharmaceuticals, Inc. (AGIO)
is a Sell
Is Agios Pharmaceuticals, Inc. overpriced?
-
Agios Pharmaceuticals, Inc. has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Agios Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
agios.com
52-Week Data
52-Week High:
62.45
52-Week Low:
22.24
Prediction Charts
Market Cap:
1.6B
Price in USD:
27.42
Volume:
1.2M
Beta:
1.35
Technical Analysis
SMA50:
38.39
SMA100:
37.99
SMA200:
34.82
52-Wk Change:
-53.88%
Stock Predictions
-
Is Agios Pharmaceuticals, Inc. stock public?Yes, Agios Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Agios Pharmaceuticals, Inc. stock quote today?The Agios Pharmaceuticals, Inc. stock price is 27.42 USD today.
-
How to buy Agios Pharmaceuticals, Inc. stock online?You can buy Agios Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 41.89 | 43.65 | 44.29 | 41.34 |
| Nov-17 | 43.59 | 45.13 | 45.96 | 42.50 |
| Nov-18 | 44.92 | 45.49 | 46.00 | 44.40 |
| Nov-19 | 23.29 | 22.34 | 25.07 | 22.24 |
| Nov-20 | 23.30 | 24.57 | 25.98 | 23.05 |
| Nov-21 | 24.66 | 25.24 | 25.94 | 23.00 |
| Nov-24 | 25.56 | 26.49 | 26.75 | 24.96 |
| Nov-25 | 27.19 | 28.43 | 28.63 | 26.36 |
| Nov-26 | 28.85 | 29.04 | 29.46 | 27.84 |
| Nov-28 | 29.30 | 29.20 | 29.30 | 28.45 |
| Dec-1 | 28.51 | 27.84 | 28.55 | 27.63 |
| Dec-2 | 27.74 | 26.98 | 27.99 | 26.81 |
| Dec-3 | 27.15 | 27.49 | 27.73 | 26.99 |
| Dec-4 | 27.35 | 27.42 | 27.69 | 27.13 |
Agios Pharmaceuticals, Inc. Earnings
Agios Pharmaceuticals, Inc. Earnings Report: Per Share Agios Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Agios Pharmaceuticals, Inc. Forecast Revenue Growth
Agios Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Agios Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.22 per share, and an increase next year of $0.52 per share.
* Agios Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.